These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 27836713)
1. Early enteric neuron dysfunction in mouse and human Huntington disease. Sciacca S; Favellato M; Madonna M; Metro D; Marano M; Squitieri F Parkinsonism Relat Disord; 2017 Jan; 34():73-74. PubMed ID: 27836713 [No Abstract] [Full Text] [Related]
2. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease. Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486 [TBL] [Abstract][Full Text] [Related]
3. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease. Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753 [TBL] [Abstract][Full Text] [Related]
5. p35 hemizygosity activates Akt but does not improve motor function in the YAC128 mouse model of Huntington's disease. Park KHJ; Franciosi S; Parrant K; Lu G; Leavitt BR Neuroscience; 2017 Jun; 352():79-87. PubMed ID: 28391013 [TBL] [Abstract][Full Text] [Related]
6. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease. Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201 [TBL] [Abstract][Full Text] [Related]
15. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801 [TBL] [Abstract][Full Text] [Related]
16. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice. Pouladi MA; Stanek LM; Xie Y; Franciosi S; Southwell AL; Deng Y; Butland S; Zhang W; Cheng SH; Shihabuddin LS; Hayden MR Hum Mol Genet; 2012 May; 21(10):2219-32. PubMed ID: 22328089 [TBL] [Abstract][Full Text] [Related]
17. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease. Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081 [TBL] [Abstract][Full Text] [Related]
18. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Slow EJ; Graham RK; Osmand AP; Devon RS; Lu G; Deng Y; Pearson J; Vaid K; Bissada N; Wetzel R; Leavitt BR; Hayden MR Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11402-7. PubMed ID: 16076956 [TBL] [Abstract][Full Text] [Related]